ERCC1 and non-small cell lung carcinoma: Furthermore, ERCC1 expression has been negatively correlated with survival after cisplatin chemotherapy in patients with non-small cell lung cancer (NSCLC) and is being exploited as a prognostic factor in the clinic25.